SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-019370
Filing Date
2021-08-11
Accepted
2021-08-11 08:00:59
Documents
48
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20210630_10q.htm   iXBRL 10-Q 643729
2 EXHIBIT 31.1 ex_272460.htm EX-31.1 9014
3 EXHIBIT 31.2 ex_272461.htm EX-31.2 8918
4 EXHIBIT 32.1 ex_272462.htm EX-32.1 4730
5 EXHIBIT 32.2 ex_272463.htm EX-32.2 4679
11 dffn20210630_10qimg001.gif GRAPHIC 3024
  Complete submission text file 0001437749-21-019370.txt   3092079

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20210630.xsd EX-101.SCH 32382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20210630_cal.xml EX-101.CAL 23622
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20210630_def.xml EX-101.DEF 198209
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20210630_lab.xml EX-101.LAB 205546
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20210630_pre.xml EX-101.PRE 218099
12 EXTRACTED XBRL INSTANCE DOCUMENT dffn20210630_10q_htm.xml XML 382068
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 211162027
SIC: 2834 Pharmaceutical Preparations